Gene · 3020
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A more accurate analysis of maternal effect genes by siRNA electroporation into mouse oocytes. | J Reprod Dev | 2023 | 36858514 | PubTator, text mining | PubMed |
| A rare case of H3K27-altered diffuse midline glioma with multiple osseous and spinal metastases at the time of diagnosis. | BMC Neurol | 2023 | 36855102 | PubTator, text mining | PubMed |
| Emerging Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma: A Systematic Review. | Healthcare (Basel) | 2023 | 36833093 | PubTator, text mining | PubMed |
| A Primary Kidney Giant Cell Tumor of Soft Tissue Caused Peritoneal Dissemination, Considered to Be Malignant Transformation: A Case Report. | Diagnostics (Basel) | 2023 | 36832239 | PubTator, text mining | PubMed |
| Towards Standardisation of a Diffuse Midline Glioma Patient-Derived Xenograft Mouse Model Based on Suspension Matrices for Preclinical Research. | Biomedicines | 2023 | 36831063 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas. | Nat Commun | 2023 | 36823172 | PubTator, text mining | PubMed |
| Images of giant cell tumor and chondroblastoma around the knee: retrospective analysis of 99 cases. | Quant Imaging Med Surg | 2023 | 36819259 | PubTator, text mining | PubMed |
| SMYD Family Members Serve as Potential Prognostic Markers and Correlate with Immune Infiltrates in Gastric Cancer. | J Oncol | 2023 | 36816359 | PubTator, text mining | PubMed |
| Long term outcome of surgical treatment of chondroblastoma: analysis of local control and growth plate/articular cartilage related complications. | BMC Musculoskelet Disord | 2023 | 36814214 | PubTator, text mining | PubMed |
| Giant cell tumor of bone with H3F3B mutation: A case report. | Medicine (Baltimore) | 2023 | 36800629 | PubTator, text mining | PubMed |
| CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population. | Acta Neuropathol Commun | 2023 | 36782314 | PubTator, text mining | PubMed |
| Giant-cell-poor giant cell tumor of bone: report of two cases and literature review. | Skeletal Radiol | 2023 | 36781420 | PubTator, text mining | PubMed |
| Extraskeletal Ewing's sarcoma of the mediastinum: Case report. | Front Oncol | 2023 | 36776337 | PubTator, text mining | PubMed |
| Cellular and molecular features related to exceptional therapy response and extreme long-term survival in glioblastoma. | Cancer Med | 2023 | 36776000 | PubTator, text mining | PubMed |
| Current state of pediatric neuro-oncology imaging, challenges and future directions. | Neoplasia | 2023 | 36774835 | PubTator, text mining | PubMed |
| Endometriosis of the Cervix: A Rare Clinical Case with the Possibility of Comparing the Eutopic and Ectopic Endometrium at the Cellular Level. | Int J Mol Sci | 2023 | 36768508 | PubTator, text mining | PubMed |
| Defining a Correlative Transcriptional Signature Associated with Bulk Histone H3 Acetylation Levels in Adult Glioblastomas. | Cells | 2023 | 36766715 | PubTator, text mining | PubMed |
| A Highly Sensitive Flow Cytometric Approach to Detect Rare Antigen-Specific T Cells: Development and Comparison to Standard Monitoring Tools. | Cancers (Basel) | 2023 | 36765532 | PubTator, text mining | PubMed |
| Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways. | Acta Neuropathol Commun | 2023 | 36759899 | PubTator, text mining | PubMed |
| H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics. | Expert Opin Ther Targets | 2023 | 36744399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3020/papers?page=18